HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Comparison of mycophenolate mofetil and azathioprine for prevention of bronchiolitis obliterans syndrome in de novo lung transplant recipients.

AbstractBACKGROUND:
There are no data on the effects of mycophenolate mofetil (MMF) on the incidence of bronchiolitis obliterans syndrome (BOS) in lung-transplant patients. This study attempted to determine whether MMF reduces the incidence of BOS in de novo lung transplant recipients compared with azathioprine (AZA).
METHODS:
This prospective, randomized, open-label, multicenter study compared the effects of MMF with AZA in combination with induction therapy, cyclosporine (Neoral) and corticosteroids in patients receiving their first lung transplant. Primary endpoint was incidence of BOS at 3 years. Secondary endpoints were incidence of acute rejection, time to first rejection event, and survival.
RESULTS:
The incidence of acute rejection and the time to first rejection event at 1 and 3 years did not differ between groups (54.1% vs. 53.8% and 56.6% vs. 60.3% for MMF and AZA respectively). Survival at 1 year tended to be better in patients receiving MMF (88 vs. 80%, P = 0.07). At year 3, there was no difference in survival or in the incidence, severity or time to acquisition of BOS between the two groups. Treatment was generally well tolerated, however more patients withdrew from AZA treatment than from MMF (59.6% vs. 46.5%, P = 0.02). As a result, there was an imbalance in the observation times of the two groups (876 +/- 395 vs. 947 +/- 326 days).
CONCLUSIONS:
No differences were seen in the incidence of acute rejection or BOS in lung transplant recipients treated with MMF or AZA. This null result may have been influenced by the shorter observation time for AZA patients.
AuthorsKeith McNeil, Allan R Glanville, Thorsten Wahlers, Christiane Knoop, Rudolf Speich, Richard D Mamelok, Joerg Maurer, Jane Ives, Paul A Corris
JournalTransplantation (Transplantation) Vol. 81 Issue 7 Pg. 998-1003 (Apr 15 2006) ISSN: 0041-1337 [Print] United States
PMID16612275 (Publication Type: Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Immunosuppressive Agents
  • Mycophenolic Acid
  • Azathioprine
Topics
  • Adolescent
  • Adult
  • Aged
  • Azathioprine (adverse effects, therapeutic use)
  • Bronchiolitis Obliterans (etiology, prevention & control)
  • Drug Therapy, Combination
  • Graft Rejection (prevention & control)
  • Humans
  • Immunosuppressive Agents (therapeutic use)
  • Lung Transplantation (adverse effects, immunology)
  • Middle Aged
  • Mycophenolic Acid (adverse effects, analogs & derivatives, therapeutic use)
  • Prospective Studies
  • Syndrome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: